close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about KYMR

Recent news which mentions KYMR

< Previous 1 2 3 4 Next >
During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share
Tickers KYMR
Tags Analyst Rating KYMR News
From Best Stocks
5 Analysts Have This to Say About Kymera Therapeutics
Tickers KYMR
Tags Benzinga Market News Analyst Ratings
From Benzinga
Kymera Therapeutics: Q2 Earnings Insights
Tickers KYMR
Tags Benzinga Market News Earnings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
Tickers AAWW AINV ATHE BNET
Tags XPEV CLW HYFM
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
Tickers A ACLX ALB ALLY
Tags Benzinga AXTA ALLY
From Benzinga
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Tickers KYMR
Tags Small Cap Patient Enrollment General
From Benzinga
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Tickers AKRO ATNF BNTX CALA
Tags OMGA Movers Contracts
From Benzinga
Why Kymera Therapeutics Stock Is Gaining Wednesday
Tickers KYMR
Tags Benzinga FDA Biotech
From Benzinga
Analyst Ratings for Kymera Therapeutics
Tickers KYMR
Tags Analyst Ratings Market News Benzinga
From Benzinga
Fresh Del Monte Produce And 2 Other Stocks Insiders Are Buying
Tickers FDP KYMR NSIT
Tags Insider Buying Small Cap Market News
From Benzinga
3 Biotech Stocks to Buy Before They Boom
Tickers BHVN GSK IBB JNJ
Tags SNY Market News Stocks to Buy
From InvestorPlace
Executives Buy Around $141M Of 4 Stocks
Tickers APPN IHRT KYMR UBER
Tags News Insider Trades APPN
From Benzinga
81 Biggest Movers From Yesterday
Tickers ACON AIKI AIU AKAM
Tags SMLP IDAI HCP
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACON AKAM AMRN ANDE
Tags KYMR QUAD Trading Ideas
From Benzinga
80 Biggest Movers From Yesterday
Tickers AERC ARRY ATKR ATNF
Tags BWV CRXT MPWR
From Benzinga
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher
Tickers BLTE BORR CHGG ENVX
Tags BLTE Eurozone Intraday Update
From Benzinga
Why Kymera Therapeutics Shares Are Falling Today
Tickers KYMR SNY
Tags KYMR Briefs Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ATNF ATNX BLTE BMEA
Tags ATNF SESN BLTE
From Benzinga
Why Kymera Therapeutics Stock Is Getting Hammered Today
Tickers KYMR PFE SNY
Tags Recent Press Releases Market News PFE
From Motley Fool
Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge
Tickers BLTE CHGG CVI ENVX
Tags TTI KYMR Markets
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
Tickers ATKR BLBX BLTE BP
Tags FMC CVI ATKR
From Benzinga
Kymera Therapeutics: Q1 Earnings Insights
Tickers KYMR
Tags KYMR Earnings Benzinga
From Benzinga
Analyst Ratings for Kymera Therapeutics
Tickers KYMR
Tags KYMR BZI/AAR Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
Tickers ACHR ALL AM ARVN
Tags MC AVDX BBLN
From Benzinga
Kymera Therapeutics Q1 2022 Earnings Conference Call On May 3, 2022 At 08:00 AM ET
Tickers KYMR
Tags KYMR Earnings BZI/CONF
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ARQT BMY CCXI KYMR
Tags Options ARQT Market News
From Benzinga
JPMorgan Sees 'Limited Upside Potential' In Kymera Therapeutics' KT-474
Tickers KYMR SNY
Tags Initiation Briefs KYMR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022
Tickers AMR ANET ASAN AVA
Tags FOUR Upgrades ASAN
From Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
Tickers ARVN BIIB CCCC GOOG
Tags GOOG PFE BIIB
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
Tickers AIG AMBA ARVN AXP
Tags BURL AIG IVAC
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today